Inhibition of ATM with KU-55933 Sensitizes Endometrial Cancer Cell Lines to Olaparib
Article in OncoTargets and Therapy (December 2023)
The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.
Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma
Article in Cell Reports (October 2023)
Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancer
Article in npj Breast Cancer (May 2023)